High materiality7/10
Axsome Therapeutics initiated with an Outperform at BMO Capital
Why it may matterVerify against the original reporting
Bullish setup
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
BMO Capital initiated coverage with Outperform; target price $310; current price $221.64.
- BMO starts coverage with Outperform; target $310; price $221.64.
Key facts
- 01
Target: $310
- 02
Posted price: $221.64
- 03
Analyst firm: BMO Capital
- 04
Analyst: Malcolm Hoffman
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.